• Fumagillin Beyond Angiogenesis: Protocol Precision and Trans

  2026-05-11

  Explore Fumagillin's role as a methionine aminopeptidase-2 inhibitor, with a focus on protocol-critical parameters and translational boundaries in cancer and antiparasitic research. Gain actionable, evidence-based guidance unavailable in standard workflow articles.

• Novobiocin Sodium in Dynamic DNA Replication and Membrane Re

  2026-05-11

  Discover the multifaceted applications of Novobiocin Sodium, an aminocoumarin antibiotic, in advanced DNA replication and membrane biosynthesis research. This article provides a unique, assay-focused analysis, integrating mechanistic insights with practical guidance for metabolic enzyme and apoptosis pathway studies.

• Angiotensin (1-7): Mechanisms, Validation, and Translational

  2026-05-10

  Explore how Angiotensin (1-7) (Asp-Arg-Val-Tyr-Ile-His-Pro) drives next-generation translational research through Mas receptor modulation, PI3K/AKT and ERK pathway regulation, and anti-fibrotic, anti-inflammatory, and neuroprotective effects. This thought-leadership article bridges molecular rationale, experimental validation, clinical potential, and strategic workflow guidance, advancing beyond standard product pages for a holistic, evidence-based perspective.

• Nicotinamide Adenine Dinucleotide (NAD+): Experimental Workf

  2026-05-09

  Nicotinamide Adenine Dinucleotide (NAD+) is pivotal for dissecting metabolic signaling and autophagy, especially following new discoveries that challenge established paradigms. This article delivers actionable protocols, troubleshooting strategies, and contextualizes NAD+ in next-generation energy stress research.

• Fluorouracil in Solid Tumor Research: Protocols & Optimizati

  2026-05-09

  Fluorouracil (5-Fluorouracil) remains a gold standard for dissecting DNA replication inhibition and therapeutic heterogeneity in colon and breast cancer models. This article delivers stepwise protocols, troubleshooting guidance, and advanced workflow enhancements—integrating the latest findings from subclonal evolution in metastatic colorectal cancer.

• TMRE Mitochondrial Membrane Potential Assay Kit: Applied Ins

  2026-05-08

  The TMRE mitochondrial membrane potential assay kit empowers researchers to detect mitochondrial dysfunction with precision, enabling high-throughput, quantitative analysis of ΔΨm in both apoptosis and metabolic studies. Its robust workflow, built-in controls, and superior sensitivity make it the gold standard for evaluating mitochondrial health in diverse experimental contexts.

• Mecamylamine Hydrochloride: A Precision Tool for Neuropsychi

  2026-05-07

  Explore how Mecamylamine hydrochloride enables advanced studies of nicotinic acetylcholine receptor signaling in neuropsychiatric disorders. This article reveals new insights into gut-brain cholinergic pathways and practical assay design.

• Suhuang Capsule Suppresses ER Stress and NLRP3 in Cough Vari

  2026-05-07

  This study reveals that Suhuang antitussive capsule ameliorates pulmonary dysfunction in cough variant asthma by inhibiting endoplasmic reticulum (ER) stress and NLRP3 inflammasome activation. The findings provide new mechanistic insights into the anti-inflammatory effects of Suhuang and highlight ER stress modulation as a key therapeutic axis in airway disease.

• Annexin V-Cy5/DAPI Apoptosis Kit: Precision in Cell Death An

  2026-05-06

  The Annexin V-Cy5/DAPI Apoptosis Kit accelerates and sharpens apoptosis and necrosis detection, enabling robust differentiation in as little as 10–20 minutes. Its proven workflow delivers actionable insights in translational research, exemplified by mechanistic breakthroughs in leukemia cell death modeling.

• Brain-to-Spinal Circuits Regulate Mechanical Allodynia Later

  2026-05-06

  Huo et al. (2023) identify a specific brain-to-spinal circuit involving Oprm1-expressing neurons in the lateral parabrachial nucleus and Pdyn neurons in the dorsal medial hypothalamus that regulates the laterality and duration of mechanical allodynia in mice. Their findings clarify how descending neural pathways modulate pain hypersensitivity, providing new directions for preclinical models of chronic pain.

• H-Aggregated IR-1061 Liposomes Enhance Synergistic Tumor The

  2026-05-05

  Yu et al. report a lipid nanosystem that leverages H-aggregated IR-1061 to enable potent photothermal therapy (PTT) and NIR-II fluorescence imaging for cancer treatment. This approach demonstrates enhanced membrane targeting, efficient photothermal conversion, and dual-modality therapy, with implications for the rational design of multifunctional organic fluorophores in biomedical research.

• Dihydroethidium: Precision Superoxide Sensing for Translatio

  2026-05-05

  Explore how Dihydroethidium (DHE, hydroethidine) is redefining superoxide detection in translational research. This article integrates mechanistic depth, protocol guidance, and clinical strategy—bridging recent breakthroughs in redox biology with actionable recommendations for apoptosis and cardiovascular disease research. With reference to novel ROS-driven chemotherapeutics and APExBIO’s high-purity DHE, discover how to elevate your oxidative stress assays and advance disease modeling beyond standard workflows.

• Docetaxel in Cancer Chemotherapy Research: Applied Workflows

  2026-05-04

  Docetaxel (Taxotere) stands out as a gold-standard microtubule stabilizer for dissecting cancer mechanisms and overcoming drug resistance. This guide delivers actionable workflows, troubleshooting strategies, and comparative advantages for leveraging Docetaxel in advanced oncology research models.

• Macromolecular Cryoprotectants Enable Improved Monocyte Cryo

  2026-05-04

  This study demonstrates that macromolecular cryoprotectants, including polyampholytes and ice nucleators, significantly enhance the cryopreservation and post-thaw differentiation of THP-1 monocytes by restricting intracellular ice formation. The findings suggest a path toward more scalable, high-throughput immunological assays using assay-ready cells, overcoming longstanding challenges in immune cell banking and functional recovery.

• Synergistic OXPHOS Disruption: LRPPRC Inhibition & Dasatinib

  2026-05-03

  This study uncovers a synergistic anti-tumor effect from combined LRPPRC inhibition and dasatinib treatment, uniquely disrupting both mitochondrial and nuclear-encoded OXPHOS genes. The findings establish a dual-genome targeting rationale for metabolic cancer therapy and inform optimized experimental protocols for translational research.

16459 records 1/1098 page Next 12345 下5页 Last page